The role of CD146 in renal disease: from experimental nephropathy to clinics - Des Maladies Rénales Rares aux Maladies Fréquentes, Remodelage et Réparation Access content directly
Journal Articles Journal of Molecular Medicine Year : 2023

The role of CD146 in renal disease: from experimental nephropathy to clinics

Abstract

Vascular endothelial dysfunction is a major risk factor in the development of renal diseases. Recent studies pointed out a major interest for the inter-endothelial junction protein CD146, as its expression is modulated during renal injury. Indeed, some complex mechanisms involving this adhesion molecule and its multiple ligands are observed in a large number of renal diseases in fundamental or clinical research. The purpose of this review is to summarize the most recent literature on the role of CD146 in renal pathophysiology, from experimental nephropathy to clinical trials.
Embargoed file
Embargoed file
0 0 4
Year Month Jours
Avant la publication
Thursday, May 23, 2024
Embargoed file
Thursday, May 23, 2024
Please log in to request access to the document

Dates and versions

hal-04401078 , version 1 (19-01-2024)

Identifiers

Cite

Louis Boutin, Elena Roger, Etienne Gayat, François Depret, Marcel Blot-Chabaud, et al.. The role of CD146 in renal disease: from experimental nephropathy to clinics. Journal of Molecular Medicine, 2023, ⟨10.1007/s00109-023-02392-7⟩. ⟨hal-04401078⟩
33 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More